The rapid development of modern endovascular,microsurgical,and radiati
on therapies has considerably expanded the treatment options for encep
halic arteriovenous malformations (AVMs). Surgery has the longest hist
ory. Single or staged intravascular procedures (embolizations) using f
ast-acting glues, sclerotic agents, and thrombogenic coils serve to re
duce the size of AVM to that suitable for extirpation and may reduce t
he risk of surgery. Radiation (''gamma-knife'') therapy, most frequent
ly used in small, non-operable AVMs, is also viewed by some authors as
an alternative or even superior tool in small, operable malformations
. Partial embolization to reduce the mass-effect of space-occupying AV
Ms,to reverse diaschisis, and to treat AVM-related seizure disorders i
s being discussed and practiced. Given the in part competing or even c
ontroversial options, the selection of optimal treatment for AVM patie
nts is becoming increasingly difficult. Current management is impeded
by the paucity of information on the exact risks of invasive therapies
and by insufficient criteria for identifying patients at risk of spon
taneous bleeding during the natural course, including the seriousness
of such hemorrhage.